Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Income from Continuing Operations (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Income from Continuing Operations for 6 consecutive years, with 17682000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 426.6% to 17682000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 21037000.0, a 59.78% increase, with the full-year FY2025 number at 21037000.0, up 59.8% from a year prior.
  • Income from Continuing Operations was 17682000.0 for Q4 2025 at GeneDx Holdings, down from 7636000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 10810000.0 in Q2 2025 to a low of 308713000.0 in Q4 2022.
  • A 5-year average of 61794747.85 and a median of 41235500.0 in 2021 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 280529.9% in 2021, then soared 137.05% in 2025.
  • GeneDx Holdings' Income from Continuing Operations stood at 40185000.0 in 2021, then plummeted by 668.23% to 308713000.0 in 2022, then skyrocketed by 91.66% to 25758000.0 in 2023, then skyrocketed by 121.02% to 5414000.0 in 2024, then crashed by 426.6% to 17682000.0 in 2025.
  • Per Business Quant, the three most recent readings for WGS's Income from Continuing Operations are 17682000.0 (Q4 2025), 7636000.0 (Q3 2025), and 10810000.0 (Q2 2025).